Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > generic

: 2-AI

or 2-FDCK

or Sodium Oxybate

Use the filters below to narrow your results.

None (2) · Xyrem; Xywav (lower-sodium formulation with Ca/Mg/K salts) (1)

Dissociative (1) · GABAB Agonist; Endogenous GHB receptor agonist (1) · Research material (2) · Stimulant (1)

Agonist at the metabotropic GABAB receptor and the endogenous γ-hydroxybutyrate (GHB) receptor. Produces deep sleep with increased slow-wave architecture, suppression of REM intrusion, and cataplexy reduction. (1) · Alpha-methylated amphetamine analogue; norepinephrine releasing agent (1) · NMDA antagonist; fluorinated ketamine analogue (1)

None (2) · '"`UNIQ--vote-00000717-QINU`"', '"`UNIQ--vote-00000718-QINU`"', '"`UNIQ--vote-00000719-QINU`"' (1)

None (2) · 2.25 g at bedtime + 2.25 g 2.5–4 h later; titrate weekly to 6–9 g/night total (1)

None (2) · 0.5 g/mL oral solution (1)

None (2) · 9 g/night (1)

None (2) · Oral (must be taken in bed; effects within minutes) (1)

None (2) · 15–30 min (fasting) (1)

None (2) · ~3 h per dose (twice-nightly schedule required) (1)

None (2) · 30–60 min (1)

None (2) · ~25% (high first-pass) (1)

None (2) · Category C (1)

None (2) · Schedule III; REMS-restricted (Schedule I if outside the pharmaceutical channel, same molecule as illicit GHB) (1)

Showing below up to 3 results in range #1 to #3.

2

2-AI

2-FDCK

S

Sodium Oxybate

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"